The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
So this is why I always say behavioral tools really should come first. I don't say that because I dislike pharmacology, I say that because in many cases behavioral tools are not only safer and easier to titrate to adjust the duration, et cetera than is pharmacology, but also because they can sometimes as in the case of the study we just described for you more specificity not less than pharmacology.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.